Erschienen in:
01.02.2005 | Editorial
Surviving sepsis—but for how long?
verfasst von:
Peter Dodek
Erschienen in:
Intensive Care Medicine
|
Ausgabe 2/2005
Einloggen, um Zugang zu erhalten
Excerpt
Severe sepsis, defined as infection plus a systemic response and organ dysfunction, hypoperfusion, or hypotension [
1], occurs in about 10% of patients who are cared for in intensive care units (ICUs) [
2,
3]. In the United States the attributable cost of this condition is nearly $17 billion annually [
4]. Severe sepsis is associated with a 28-day mortality that ranges between 20% [
5] and 55% [
2]. Although most of the deaths due to this condition occur during the first month after presentation, mortality has been estimated to be 45% at 5 months after admission [
3], 68% at 6 months [
6], and 72% at 1 year [
6]. In a cohort study of septic patients who had been screened for a study of corticosteroids in systemic sepsis and a control group of noninfected patients, sepsis was found to be associated with an increased risk of death up to 5 years after the septic episode [
7]. In 30-day survivors it was associated with a reduction in median survival from 6.2 to 2.4 years [
7]. Furthermore, survivors of sepsis report abnormal physical function and general health [
8]. …